Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-04

Clinical Trial Update: The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Xiidra (lifitegrast) for comfort and dryness in symptomatic contact lens wearers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xiidra (Lifitegrast)

Snippet

Sponsor: University of Waterloo | Conditions: Dry Eye | Phase 4 | Status: COMPLETED | Results posted: 2025-05-04